Eade Katherine A. bought HBIO
July 16, 2025 · Form 4 insider transaction
Eade Katherine A. bought 110,000 shares of Harvard Bioscience, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
110,000
Price
$0.00
Total value
N/A
InsiderEade Katherine A.
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 16, 2025
Filing dateJuly 18, 2025
Shares owned after421,126
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents an award of 110,000 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after July 16, 2025, immediately prior to the commencement of such meeting, and (ii) July 16, 2026.; Includes (a) the award described in footnote (1) above and (b) 311,126 shares of common stock beneficially owned by the Reporting Person.